46 related articles for article (PubMed ID: 12630292)
1. Synthesis and In Vitro Antiproliferative Activity of New 1-Phenyl-3-(4-(pyridin-3-yl)phenyl)urea Scaffold-Based Compounds.
Al-Sanea MM; Ali Khan MS; Abdelazem AZ; Lee SH; Mok PL; Gamal M; Shaker ME; Afzal M; Youssif BGM; Omar NN
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385071
[TBL] [Abstract][Full Text] [Related]
2. Applying ligands profiling using multiple extended electron distribution based field templates and feature trees similarity searching in the discovery of new generation of urea-based antineoplastic kinase inhibitors.
Dokla EM; Mahmoud AH; Elsayed MS; El-Khatib AH; Linscheid MW; Abouzid KA
PLoS One; 2012; 7(11):e49284. PubMed ID: 23185312
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of enantiomerically enriched imidazolidin-2-ones through asymmetric palladium-catalyzed alkene carboamination reactions.
Hopkins BA; Wolfe JP
Angew Chem Int Ed Engl; 2012 Sep; 51(39):9886-90. PubMed ID: 22936415
[TBL] [Abstract][Full Text] [Related]
4. Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison.
Weisberg E; Roesel J; Furet P; Bold G; Imbach P; Flörsheimer A; Caravatti G; Jiang J; Manley P; Ray A; Griffin JD
Genes Cancer; 2010 Oct; 1(10):1021-32. PubMed ID: 21779428
[TBL] [Abstract][Full Text] [Related]
5. Palladium-Catalyzed Carboetherification and Carboamination Reactions of γ-Hydroxy- and γ-Aminoalkenes for the Synthesis of Tetrahydrofurans and Pyrrolidines.
Wolfe JP
European J Org Chem; 2007 Feb; 2007(4):571-582. PubMed ID: 20577649
[TBL] [Abstract][Full Text] [Related]
6. A new synthesis of imidazolidin-2-ones via Pd-catalyzed carboamination of N-allylureas.
Fritz JA; Nakhla JS; Wolfe JP
Org Lett; 2006 Jun; 8(12):2531-4. PubMed ID: 16737306
[TBL] [Abstract][Full Text] [Related]
7. Synthetic studies toward aryl-(4-aryl-4H-[1,2,4]triazole-3-yl)-amine from 1,3-diarylthiourea as urea mimetics.
Natarajan A; Guo Y; Arthanari H; Wagner G; Halperin JA; Chorev M
J Org Chem; 2005 Aug; 70(16):6362-8. PubMed ID: 16050698
[TBL] [Abstract][Full Text] [Related]
8. Melanoma genetics and the development of rational therapeutics.
Chudnovsky Y; Khavari PA; Adams AE
J Clin Invest; 2005 Apr; 115(4):813-24. PubMed ID: 15841168
[TBL] [Abstract][Full Text] [Related]
9. Kinases as targets: prospects for chronic therapy.
Orchard S
Curr Opin Drug Discov Devel; 2002 Sep; 5(5):713-7. PubMed ID: 12630291
[TBL] [Abstract][Full Text] [Related]
10. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase inhibitors from the urea class.
Dumas J
Curr Opin Drug Discov Devel; 2002 Sep; 5(5):718-27. PubMed ID: 12630292
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis.
Pargellis C; Regan J
Curr Opin Investig Drugs; 2003 May; 4(5):566-71. PubMed ID: 12833650
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in the discovery of protein kinase inhibitors from the urea class.
Dumas J; Smith RA; Lowinger TB
Curr Opin Drug Discov Devel; 2004 Sep; 7(5):600-16. PubMed ID: 15503863
[TBL] [Abstract][Full Text] [Related]
14. Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors.
Kroe RR; Regan J; Proto A; Peet GW; Roy T; Landro LD; Fuschetto NG; Pargellis CA; Ingraham RH
J Med Chem; 2003 Oct; 46(22):4669-75. PubMed ID: 14561086
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
